SCHEMBL9888393

SCHEMBL9888393

CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(S(N)(=O)=O)c(C)c4)cc23)c1F

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 2/20 0.78
▸ CYP2C19 P33261 12/20 0.77
▸ RIPK2 O43353 1/20 0.76
▸ ABCB11 O95342 1/20 0.76
▸ EGFR P00533 1/20 0.76
▸ KRAS P01116 1/20 0.76
▸ RAF1 P04049 1/20 0.76
▸ PGR P06401 1/20 0.76
▸ RET P07949 1/20 0.76
▸ CHRM2 P08172 1/20 0.76
▸ ADORA3 P0DMS8 1/20 0.76
▸ ARAF P10398 1/20 0.76
▸ CHRM1 P11229 1/20 0.76
▸ CHRM3 P20309 1/20 0.76
▸ FECH P22830 1/20 0.76
▸ KDR P35968 1/20 0.76
▸ MAP2K2 P36507 1/20 0.76
▸ TGFBR2 P37173 1/20 0.76
▸ NEK2 P51955 1/20 0.76
▸ MAP2K1 Q02750 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10246457 0.92 CYP2C19 (0.84) BRAFCYP2C19RIPK2ABCB11EGFR
SCHEMBL29898551 0.89 CYP2C19 (0.86) BRAFCYP2C19RIPK2ABCB11EGFR
SCHEMBL299611 0.89 CYP2C19 (0.86) BRAFCYP2C19RIPK2ABCB11EGFR
SCHEMBL20400626 0.89 CYP2C9 (0.86) BRAFCYP2C19RIPK2ABCB11EGFR
SCHEMBL27103518 0.88 CYP2C19 (0.82) BRAFCYP2C19RIPK2ABCB11EGFR
SCHEMBL855840 0.88 BRAF (0.87) BRAFCYP2C19RIPK2ABCB11EGFR
SCHEMBL29898578 0.88 BRAF (0.87) BRAFCYP2C19RIPK2ABCB11EGFR
SCHEMBL2163092 0.88 CYP2C19 (0.79) BRAFCYP2C19RIPK2ABCB11EGFR
SCHEMBL299516 0.87 CYP2C19 (0.86) BRAFCYP2C19RIPK2ABCB11EGFR
SCHEMBL20294636 0.87 BRAF (1.00) BRAFCYP2C19RIPK2ABCB11EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8198273-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2012-06-12 — — US claimed
Send feedback